Stem cell-derived therapeutic myelin repair requires 7% cell replacement

Stem Cells

Volumn 26, Issue 9, 2008, Pages 2229-2236

  Kiel, Mary E ^a   Chen, Cui P ^a   Sadowski, Dorota ^a   Mckinnon, Randall D ^a,b  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b Department of Molecular Genetics Microbiology ^*  (United States)

Author keywords

Cell transplantation; Embryonic stem cells; Glia; Oligodendrocytes; Thresholds

Indexed keywords

MYELIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; C57BL 6 MOUSE; CELL REGENERATION; CELL THERAPY; CELL TRANSPLANTATION; CHIMERA; CONTROLLED STUDY; EMBRYONIC STEM CELL; ENGRAFTMENT; GENOTYPE; IMMUNOCYTOCHEMISTRY; MOTOR PERFORMANCE; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; QUANTITATIVE ANALYSIS;

ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; CHIMERA; EMBRYONIC STEM CELLS; LONGEVITY; MICE; MICE, MUTANT STRAINS; MOTOR ACTIVITY; MYELIN BASIC PROTEINS; MYELIN SHEATH; REGENERATION;

MURINAE; MUS;

EID: 55049110425     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.2008-0218     Document Type: Article

References (43)

1. Lindvall O, Kokaia Z. Stem cells for the treatment of neurological disorders. Nature 2006;441:1094 -1096.
2. Björklund A, Dunnett SB, Brundin P et al. Neural transplantation for the treatment of Parkinson's disease. Lancet Neurol 2003;2:437- 445.
3. Frohman EM, Racke MK, Raine CS. Medical progress: Multiple sclerosis-The plaque and its pathogenesis. N Engl J Med 2006;354:942-955.
4. Chen CP, Kiel ME, Sadowski D, McKinnon RD. From stem cells to oligodendrocytes: Prospects for brain therapy. Stem Cell Reviews 2007;3:280-288.
5. Reynolds RA, Weiss S. Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science 1992;255:1707-1710.
6. Davis AA, Temple S. A self-renewing multipotential stem-cell in embryonic rat cerebral-cortex. Nature 1994;372:263-266.
7. Morshead CM, Reynolds BA, Craig CG et al. Neural stem cells in the adult mammalian forebrain: a relatively quiescent subpopulation of sub-ependymal cells. Neuron 1994;13:1071-1082.
8. Uchida N, Buck DW, He DP et al. Direct isolation of human central nervous system stem cells. Proc Natl Acad Sci U S A 2000;97:14720-14725.
9. Evans MJ, Kaufman MH. Establishment in culture of pluripotential cells from mouse embryos. Nature 1981;292:154-156.
10. Martin GR. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci U S A 1981:78;7634-7638.
11. Bradley A, Evans M, Kaufman MH, Robertson E. Formation of germline chimeras from embryo-derived teratocarcinoma cell-lines. Nature 1984;309:255-256.
12. Thomson JA, Itskovitz-Eldor J, Shapiro SS et al. Embryonic stem cell lines derived from human blastocysts. Science 1998;282:1145-1147.
13. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006;126:663-676.
14. Wernig M, Meissner A, Foreman R et al. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 2007;448:318-324.
15. Okita K, Ichisaka T, Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature 2007;448:313-317.
16. Freed CR, Breeze RE, Greene P et al. Transplanted dopaminergic neurons: More or less? Reply [letter]. Nat Med 2001;7:512-513.
17. Bird TD, Farrell DF, Sumi SM. Genetic developmental myelin defect in shiverer mouse. Trans Am Soc Neurochem 1977;8:153.
18. Jacque C, Privat A, Dupouey P et al. Shiverer mouse: A dysmyelinating mutant with absence of major dense line and basic protein in myelin. Proc Eur Soc Neurochem 1978;1:131.
19. Pfeiffer SE, Warrington AE, Bansal R. The oligodendrocyte and its many cellular processes. Trends Cell Biol 1993;3:191-197.
20. Brüstle O, Jones KN, Learish RD et al. Embryonic stem cell-derived glial precursors: A source of myelinating transplants. Science 1999;285:754-756.
21. Perez-Bouza A, Glaser T, Brustle O. ES cell-derived glial precursors contribute to remyelination in acutely demyelinated spinal cord lesions. Brain Pathol 2005;15:208-216.
22. Keirstead HS, Nistor G, Bernal G et al. Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury. J Neurosci 2005;25:4694-4705.
23. Izrael M, Zhang PL, Kaufman R et al. Human oligodendrocytes derived from embryonic stem cells: Effect of noggin on phenotypic differentiation in vitro and on myelination in vivo. Mol Cell Neurosci 2007;34:310-323.
24. Groves AK, Barnett SC, Franklin RJM et al. Repair of demyelinated lesions by transplantation of purified O-2A progenitor cells. Nature 1993;362:453-455.
25. Warrington AE, Barbarese E, Pfeiffer SE. Stage specific, (O4+GalC-) isolated oligodendrocyte progenitors produce MBP+ myelin in vivo. Dev Neurosci 1992;14:93-97.
26. Tontsch U, Archer DR, Dubois-Dalcq M, Duncan ID. Transplantation of an oligodendrocyte cell line leading to extensive myelination. Proc Natl Acad Sci U S A 1994;91:11616 -11620.
27. Readhead C, Popko B, Takahashi N et al. Expression of a myelin basic protein gene in transgenic shiverer mice: Correction of the dysmyelinating phenotype. Cell 1987;48:703-712.
28. Xian HQ, McNichols E, St Clair A, Gottlieb DI. A subset of ES-cell-derived neural cells marked by gene targeting. Stem Cells 2003;21:41- 49.
29. Billon N, Jolicoeur C, Ying QL et al. Normal timing of oligodendrocyte development from genetically engineered, lineage-selectable mouse ES cells. J Cell Sci 2002;115:3657-3665.
30. Sommer I, Schachner M. Monoclonal antibodies (01 to 04) to oligodendrocyte cell surfaces: An immunocytological study in the central nervous. Dev Biol 1981;83:311-327.
31. Ranscht B, Clapshaw PA, Price J et al. Development of oligodendrocytes and Schwann cells studied with a monoclonal antibody against galactocerebroside. Proc Natl Acad Sci U S A 1982;79:2709-2713.
32. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(T)(-Δ Δ C) method. Methods 2001;25:402-408.
33. Molineaux SM, Engh H, De Ferra F et al. Recombination within the myelin basic protein gene created the dysmyeinating shiverer mouse mutation. Proc Natl Acad Sci U S A 1986;83:7542-7546.
34. Gumpel M, Baumann N, Raoul M, Jacque C. Survival and differentiation of oligodendrocytes from neural tissue transplanted into new-born mouse brain. Neurosci Lett 1983;37:307-311.
35. Lachapelle F, Gumpel M, Baulac M et al. Transplantation of CNS fragments into the brain of shiverer mutant mice: Extensive myelination by implanted oligodendrocytes. I. Immunohistochemical Studies. Dev Neurosci 1983;6:325-334.
36. Gansmuller A, Lachapelle F, Baron-Van Evercooren A et al. Transplantation of newborn CNS fragments into the brain of shiverer mutant mice: Extensive myelination by transplanted oligodendrocytes. II. Electron microscopic study. Dev Neurosci 1986;8:197-207.
37. Kuhn PL, Petroulakais E, Zazanis GA, McKinnon RD. Motor function analysis of myelin mutant mice using a rotarod. Int J Dev Neurosci 1995;13:715-722.
38. Chernoff GF. Shiverer: An autosomal recessive mutant mouse with myelin deficiency. J Hered 1981;72:128.
39. McKinnon RD, Smith C, Behar T et al. Distinct effects of bFGF and PDGF on oligodendrocyte progenitor cells. Glia 1993;7:245-254.
40. Lu QR, Sun T, Zhu Z et al. Common developmental requirement for olig function indicates a motor neuron/oligodendrocyte connection. Cell 2002;109:75-86.
41. Vogel F, Hemmer B. New immunomodulatory treatment strategies in multiple sclerosis. Nervenheilkunde 2002;21:508-511.
42. Marrie RA, Rudick RA. Drug Insight: Interferon treatment in multiple sclerosis. Nat Clin Pract Neurol 2006;2:34-44.
43. Wakayama T, Tabar V, Rodriguez I et al. Differentiation of embryonic stem cell lines generated from adult somatic cells by nuclear transfer. Science 2001;292:740-743.